» Articles » PMID: 14961581

Cervical Cancer As a Priority for Prevention in Different World Regions: an Evaluation Using Years of Life Lost

Overview
Journal Int J Cancer
Specialty Oncology
Date 2004 Feb 13
PMID 14961581
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

The relative importance of cancer of the cervix among several important causes of mortality (from cancer and other diseases) has been evaluated by estimating the years of life lost (YLL) by young and middle-aged women (25-64 years old) in different regions of the world. The life years were weighted to reflect their importance to the individual and to society. On a global basis, cancer of the cervix is responsible for about 2% of the total (weighted) YLL, fewer than for other causes of mortality in this age group. However, it is the most important cause of YLL in Latin America and the Caribbean. It also makes the largest contribution to YLL from cancer in the populous regions of SubSaharan Africa and South-Central Asia where the actual risk of loss of life from this cause is higher, although overshadowed by noncancer deaths (from AIDS, TB and maternal conditions). The overall picture is not very sensitive to the age weighting function used. The fact that most of the loss of life is preventable, and that simple technologies have been developed that make this practicable, means that cervical cancer has an even higher profile from the perspective of resource allocation in low income settings.

Citing Articles

Vaginal microbiome distinction in women with HPV+, cervical intraepithelial neoplasia, and cervical cancer, a retrospective study.

Li Y, Wu X Front Cell Infect Microbiol. 2025; 14:1483544.

PMID: 39897478 PMC: 11782028. DOI: 10.3389/fcimb.2024.1483544.


Therapeutic Strategies in Advanced Cervical Cancer Detection, Prevention and Treatment.

Sebutsoe X, Tsotetsi N, Jantjies Z, Raphela-Choma P, Choene M, Motadi L Onco Targets Ther. 2024; 17:785-801.

PMID: 39345275 PMC: 11439348. DOI: 10.2147/OTT.S475132.


ATF1 regulates MAL2 expression through inhibition of miR-630 to mediate the EMT process that promotes cervical cancer cell development and metastasis.

Cao Y, Peng Y, Tang Y J Gynecol Oncol. 2024; 36(1):e11.

PMID: 38991944 PMC: 11790996. DOI: 10.3802/jgo.2025.36.e11.


Feasibility and acceptability of an HPV self-testing strategy: lessons from a research context to assess for ability to implement into primary care at a national level in Botswana.

Luckett R, Ramogola-Masire D, Harris D, Gompers A, Gaborone K, Mochoba L Front Glob Womens Health. 2024; 4:1300788.

PMID: 38259634 PMC: 10800890. DOI: 10.3389/fgwh.2023.1300788.


High Rate of Loss to Follow-Up Among Patients Undergoing Treatment for Premalignant Cervical Lesions at Mbarara Regional Referral Hospital, Southwestern Uganda: A Retrospective Cohort Study.

Kajabwangu R, Ssedyabane F, Tusubira D, Maling S, Kakongi N, Turyakira E Cureus. 2023; 15(10):e46542.

PMID: 37927695 PMC: 10625478. DOI: 10.7759/cureus.46542.


References
1.
Dempsey M . Decline in tuberculosis; the death rate fails to tell the entire story. Am Rev Tuberc. 2010; 56(2):157-64. DOI: 10.1164/art.1947.56.2.157. View

2.
Murray C, Lopez A . Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997; 349(9064):1498-504. DOI: 10.1016/S0140-6736(96)07492-2. View

3.
Laara E, Day N, Hakama M . Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet. 1987; 1(8544):1247-9. DOI: 10.1016/s0140-6736(87)92695-x. View

4.
Haenszel W . A standardized rate for mortality defined in units of lost years of life. Am J Public Health Nations Health. 1950; 40(1):17-26. PMC: 1528498. DOI: 10.2105/ajph.40.1.17. View

5.
Parkin D, Bray F, Ferlay J, Pisani P . Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001; 94(2):153-6. DOI: 10.1002/ijc.1440. View